Eczema in young individuals remains a substantial public health burden in most countries

NewsGuard 100/100 Score

New research published in Clinical & Experimental Allergy indicates that the burden related to eczema in young individuals is substantial in most countries. A median of 6% of both children and adolescents experience some form of eczema while 0.6% and 1.1% of children and adolescents, respectively, report symptoms of severe eczema.

The results come from an analysis of data from 14 countries involving 74,361 adolescents aged 13–14 years and 47,907 children aged 6–7 years.

Investigators estimated an average increase over 27 years in the prevalence of current eczema symptoms of 0.98% per decade in adolescents and 1.21% per decade in children, and of 0.26% and 0.23% per decade in severe eczema symptoms. However, there was substantial variation in changes in eczema prevalence over time by income and region.

Eczema remains a big public health problem around the world. Global research efforts are needed to address the burden related to eczema with continued international efforts to identify strategies to prevent the onset of eczema and to better manage the impact on individuals, their families, and health service."

Sinéad Langan, PhD, Corresponding Author, London School of Hygiene & Tropical Medicine

Source:

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Blood protein could be a potential biomarker for delayed concussion recovery in children